Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Texas Heart Institute patents


Recent patent applications related to Texas Heart Institute. Texas Heart Institute is listed as an Agent/Assignee. Note: Texas Heart Institute may have other listings under different names/spellings. We're not affiliated with Texas Heart Institute, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | Texas Heart Institute-related inventors


Magnetic assisted in-situ tubular stentgraft fenestration

A magnet assisted surgical device, system, and method employs magnetic sections, catheters, and guidewires to modify tubular stentgrafts in-situ. One example application provides a more reliable way for surgeons to modify stentgrafts insitu to allow blood flow to continue to branching blood vessels that would otherwise be blocked by the stentgraft itself. ... Texas Heart Institute

Hippo and dystrophin complex signaling in cardiomyocyte renewal

Embodiments of the disclosure include methods and compositions for the renewal of cardiomyocytes by targeting the hippo pathway. In particular embodiments, an individual with a need for cardiomyocyte renewal is provided an effective amount of a shrna molecule that targets the sav1 gene. ... Texas Heart Institute

Device and system for insertion of penetrating member

A system, device and method for insertion of a penetrating member into tissue is disclosed, which may be handheld and automated. A detector obtains data regarding subdermal locations of tissue structures, including cavities such as blood vessels. ... Texas Heart Institute

Systems and methods for attaching flexible conductive filaments, networks, or patches to tissue via catheter delivery

Systems and methods for deploying and securing conductive materials to a region of tissue may utilize a catheter. The catheter may provide a tip with one or more detachable sections or may provide an adjustable opening. ... Texas Heart Institute

Methods of enhancing stem cell engraftment

An effective amount of a composition comprising a stem cell, a stem cell engraftment enhancer, and a carrier fluid, for use in the treatment of an individual having a disease or at risk of developing a disease, wherein the disease is a vascular-associated disease and/or a muscular disease. A composition comprising pgi2-overexpressing human mesenchymal stem cells (pgi2-hmscs), and a carrier fluid; wherein an effective amount of the composition is administered via a single treatment stream as an intramuscular injection to an individual having a disease or at risk of developing a disease, wherein the disease is a vascular-associated disease and/or a muscular disease, and wherein stem cell engraftment is enhanced in said individual by greater than about 200%, when compared to stem cell engraftment in an individual treated with a composition lacking the stem cell engraftment enhancer.. ... Texas Heart Institute

Agonists that enhance binding of integrin-expressing cells to integrin receptors

A method of enhancing binding of cells to an integrin-binding ligand comprises treating integrin-expressing cells in vitro with an agonist of integrin, wherein the integrin is selected from the group consisting of α4β1, α5β1, α4β7, αvβ3 and αlβ2, and contacting the treated cells with an integrin-binding ligand; integrin agonist compounds having the general formula i; methods of treating integrin-expressing cells with such agonists to enhance binding; and therapeutic methods comprising administering agonist-treated cells or agonist compounds to a mammal.. . ... Texas Heart Institute

Methods of using cyclooxygenase-prostacyclin synthase fusion gene

An effective amount of a composition comprising (i) a plasmid having a cyclooxygenase-prostacyclin synthase fusion gene, and (ii) a carrier fluid for use in treating an individual having a vascular disease or at risk of developing a vascular disease. A composition comprising a carrier fluid; and a dna sequence encoding for a triple catalytic enzyme, a cdna sequence encoding for a triple catalytic enzyme, a plasmid comprising a dna sequence encoding for a triple catalytic enzyme, a fusion gene encoding for a triple catalytic enzyme, a cyclooxygenase-prostacyclin synthase fusion gene, or combinations thereof, for use in treating an individual having a vascular disease or at risk of developing a vascular disease.. ... Texas Heart Institute

Method and device for detection of arrhythmias and myocardial injury

Herein disclosed is a method of detecting and identifying the source of abnormal electrical currents in the heart to assist in ablating these currents, comprising the use of contact or non-contact temperature measurement devices. In an embodiment, source of abnormal electrical activity of the heart and its attached arteries and veins show different temperature patterns from normal segments. ... Texas Heart Institute








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Texas Heart Institute in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Texas Heart Institute with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###